Francesca Satolli
Overview
Explore the profile of Francesca Satolli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
88
Citations
230
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Felici Del Giudice M, Ravaglia G, Brusasco M, Satolli F
J Clin Med
. 2025 Feb;
14(3).
PMID: 39941467
: Psoriasis (PSO) and atopic dermatitis (AD) have traditionally been considered distinct diseases, respectively, mediated by T-helper 1 (Th1) and the T-helper 2 (Th2) immune pathway. In recent years, there...
2.
Bardazzi F, Filippi F, Mussi M, Lasagni C, Bigi L, Odorici G, et al.
Dermatol Pract Concept
. 2024 Aug;
14(3).
PMID: 39122529
Introduction: Historically, difficult-to-treat areas in psoriasis included face, scalp, folds, genitalia, nails, and palmoplantar region. Recent studies have found that lower limbs behave like a "new" difficult-to-treat area as they...
3.
Borghi A, Odorici G, Bardazzi F, Filippi F, Bigi L, Lasagni C, et al.
Dermatol Pract Concept
. 2024 Aug;
14(3).
PMID: 39122527
No abstract available.
4.
Gerosa S, DE Felici Del Giudice M, Macchi S, Feliciani C, Satolli F
Ital J Dermatol Venerol
. 2024 Aug;
159(5):586-587.
PMID: 39093030
No abstract available.
5.
Brusasco M, Kalaja A, Satolli F, Feliciani C, de Felici Del Giudice M
Acta Dermatovenerol Croat
. 2024 Jul;
32(1):71-72.
PMID: 38946190
A 39-year-old Caucasian woman affected by Noonan Syndrome (NS) mutated in RAF1 was referred to us with itchy lesions on her limbs that had appeared two months earlier. Clinically, there...
6.
Gargiulo L, Ibba L, Cascio Ingurgio R, Malagoli P, Amoruso F, Balato A, et al.
J Dermatolog Treat
. 2024 May;
35(1):2350760.
PMID: 38714323
Purpose: Tildrakizumab is a selective inhibitor of IL-23 approved for the treatment of moderate-to-severe plaque psoriasis in two dosages. We conducted a 16-week multicenter retrospective study to compare the effectiveness...
7.
Brusasco M, Kalaja A, Satolli F, Feliciani C, de Felici Del Giudice M
Acta Dermatovenerol Croat
. 2024 Mar;
31(3):160-161.
PMID: 38439730
A 39-year-old Caucasian woman affected by Noonan Syndrome (NS) mutated in RAF1 was referred to us with itchy lesions on her limbs that had appeared two months earlier. Clinically, there...
8.
Bellinato F, Gisondi P, Balato A, Caldarola G, Cammarata E, Campione E, et al.
J Eur Acad Dermatol Venereol
. 2023 Nov;
38(5):e391-e393.
PMID: 37909326
No abstract available.
9.
Massa A, Macchi S, Manuguerra R, Brusasco M, Aouadi M, Feliciani C, et al.
Int J Dermatol
. 2023 Sep;
62(12):e618-e620.
PMID: 37670681
No abstract available.
10.
May Lee M, Fantini C, Mori E, Feliciani C, Satolli F
Ital J Dermatol Venerol
. 2023 May;
158(4):377-378.
PMID: 37198888
No abstract available.